{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2F1l-her2-positive-mbc-u6mKk8Hu","width":444,"version":"1.0","type":"rich","title":"Oncologist On-Call: Thoughts on the Current Treatment Landscape for First-line Management of HER2-Positive mBC","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/9bc365e7-567f-4944-bb5c-320185a3ca57/100774-breast-mbc-her2-pod1-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/5a3dec70-edc6-4c84-acce-ef77fa6bb3f9\" height=\"200\" width=\"100%\" title=\"Oncologist On-Call: Thoughts on the Current Treatment Landscape for First-line Management of HER2-Positive mBC\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Audio podcast with expert insights on the current treatment landscape for first-line management of HER2-positive metastatic breast cancer considering the latest available evidence. "}